1. CD8 + T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity.
- Author
-
Snell LM, MacLeod BL, Law JC, Osokine I, Elsaesser HJ, Hezaveh K, Dickson RJ, Gavin MA, Guidos CJ, McGaha TL, and Brooks DG
- Subjects
- Animals, Antigen-Presenting Cells immunology, Antigen-Presenting Cells metabolism, Antigen-Presenting Cells virology, CD8-Positive T-Lymphocytes metabolism, CD8-Positive T-Lymphocytes virology, Cell Differentiation genetics, Chronic Disease, Gene Expression Profiling methods, Immunity genetics, Immunologic Memory genetics, Immunotherapy, Lymphocytic Choriomeningitis therapy, Lymphocytic Choriomeningitis virology, Lymphocytic choriomeningitis virus physiology, Mice, Inbred C57BL, Proteomics methods, T Cell Transcription Factor 1 genetics, T Cell Transcription Factor 1 immunology, T Cell Transcription Factor 1 metabolism, CD8-Positive T-Lymphocytes immunology, Cell Differentiation immunology, Immunity immunology, Immunologic Memory immunology, Lymphocytic Choriomeningitis immunology, Lymphocytic choriomeningitis virus immunology
- Abstract
CD8
+ T cell exhaustion impedes control of chronic viral infection; yet how new T cell responses are mounted during chronic infection is unclear. Unlike T cells primed at the onset of infection that rapidly differentiate into effectors and exhaust, we demonstrate that virus-specific CD8+ T cells primed after establishment of chronic LCMV infection preferentially generate memory-like transcription factor TCF1+ cells that were transcriptionally and proteomically distinct, less exhausted, and more responsive to immunotherapy. Mechanistically, adaptations of antigen-presenting cells and diminished T cell signaling intensity promoted differentiation of the memory-like subset at the expense of rapid effector cell differentiation, which was now highly dependent on IL-21-mediated CD4+ T cell help for its functional generation. Chronic viral infection similarly redirected de novo differentiation of tumor-specific CD8+ T cells, ultimately preventing cancer control. Thus, targeting these T cell stimulatory pathways could enable strategies to control chronic infection, tumors, and enhance immunotherapeutic efficacy., (Copyright © 2018 Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF